Mesirow Institutional Investment Management, Inc. Biomarin Pharmaceutical Inc Transaction History
Mesirow Institutional Investment Management, Inc.
- $1.27 Billion
- Q4 2024
A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 427 shares of BMRN stock, worth $22,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
427
Previous 398
7.29%
Holding current value
$22,976
Previous $27,000
3.7%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BMRN
# of Institutions
689Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$849 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$813 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$661 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...